Form 8-K - Current report:
SEC Accession No. 0001144204-14-038202
Filing Date
2014-06-18
Accepted
2014-06-18 07:38:33
Documents
2
Period of Report
2014-06-18
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v381670_8k.htm 8-K 14635
2 EXHIBIT 99.1 v381670_ex99-1.htm EX-99.1 10951
  Complete submission text file 0001144204-14-038202.txt   26914
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33357 | Film No.: 14926717
SIC: 2836 Biological Products, (No Diagnostic Substances)